|
|
Home | Search | Advance Search | Browse | Online Submission | Documentation & FAQ | Team | Contact us |
|
PolysacDB ID | 1004 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Haemophilus influenzae type B (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A relatively simple antigen consisting of repeating units of 3-β-D ribose-(1-->1)-D-ribitol-5-phosphate |
BCSDB Structure | 23423 |
Proposed Function | An important virulence determinant |
Antigenic Nature | Glycoconjugates |
Carrier Name | Neisseria meningitidis group B outer membrane protein complex (Hib PS-OMP) |
Conjugate Method | The strategy uses a oligopeptide spacer molecule whose parts are derived from both modified Haemophilus influenzae capsular polysaccharide and Neisseria meningitides group B outer membrane complex |
Antibodies | Polysera |
Antibody Type Class | IgG1 and IgG2 |
Assay System | N\A |
Cross Reactivity | N/A |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | These antibodies exert their protective effect by initiating complement-mediated activities including opsonization and bacterial lysis |
Curator ID | AA + AS |
Date of Curation | 01-01-2010 |
References | PMC296547 |
PolysacDB ID | 1005 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Haemophilus influenzae type B (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A relatively simple antigen consisting of repeating units of 3-β-D ribose-(1-->1)-D-ribitol-5-phosphate |
BCSDB Structure | 23423 |
Proposed Function | An important virulence determinant |
Antigenic Nature | Glycoconjugates |
Carrier Name | Tetanus toxoid |
Conjugate Method | Protein solutions (25 mg/ml) and Adipic acid dihydrazide [ADH] (3.45 rag/rag protein) were reacted with three different concentrations of EDAC (0 1, 0.3, and 0.6 rag/rag protein) The pH of the reaction mixture was maintained at 4.7 ± 0.2 with 0.1 N HC! The reaction proceeded at room temperature for 3 h and the reaction mixtures were dialyzed at 3-8°C with two changes/d against 6 liter of 0 2 M NaCI. The albumin and polysaccharide derivatives were then dialyzed against two 6-liter changes of deionized water and freeze-dried. The polysaccharide was activated with CNBr. Briefly, a solution of polysaccharide (5.0 mg/ml), equilibrated at 4°C, was rapidly brought to pH 10.5 with 0.1 N NaOH. 100 mg/ml CNBr was added to a final concentration of 0.4 mg/mg polysaccharide, and the pH maintained at 10.5 for 6 rain. Then the reaction mixture was brought to pH 8 5 with 0.5 M NaHCO3, and the CNBr-actlvated polysaccharide added to an equal weight of ADH-protein. The reaction mixture was tumbled gently overnight at 3-8°C and then centrifuged at 16,000 g, 4°C for 20 ram. The supernatant was passed through a CL-4B Sepharose column, 1 5 × 90 cm, that was equihbrated with 0 2 M ammonium acetate. The void-volume fractions were pooled, dialyzed against 0.01 M phosphate-buffered 0.145 M NaCI, pH 7.0, at 3-8°C, and passed through a 045-nm membrane and stored at 3-8°C |
Antibodies | Polysera |
Antibody Type Class | IgG and IgA |
Assay System | Radioimmunoassay |
Cross Reactivity | N/A |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | These antibodies exert their protective effect by initiating complement-mediated activities including opsonization and bacterial lysis |
Curator ID | AA + AS |
Date of Curation | 02-01-2010 |
References | PMC2185954 |
PolysacDB ID | 1012 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Streptococcus Group B (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A basic backbone of the following residues: -3-β-D-Galp-(1-->4) -β-D-Glcp[branched to 1-->4-D-Glp-α-D-NeuNACp]-(1-->6)-β-D-GlcNAcp-1- |
BCSDB Structure | 6237 |
Proposed Function | Invades the blood stream and multiply. This property of invasiveness is related to the anti-phagocytic properties conferred by its Capsular polysaccharide |
Antigenic Nature | Glycoconjugates |
Carrier Name | Tetanus toxoid |
Conjugate Method | Type III polysaccharide was activated with cyanogen bromide at pH 10.5 for 6 min at 4°C in a pH stat. Adipic acid dihydrazide [AH] was added in 0.5 M NaHCO3 to a final concentration of 0.25 M, pH 8.5. After tumbling for 18 h at 3 to 8°C, the reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a 4B-CL Sepharose column. The polysaccharide-containing fractions were pooled, dialyzed against sterile pyrogen-free water, and freeze-dried. A solution containing 10 mg each of type III-AH and tetanus toxoid [TT} per ml was brought to pH 5.6 with 0.1 N HCl. 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide was added to a final concentration of 0.05 M, and the pH was maintained at 5.6 with 0.1 N NaOH for 3 h at room temperature. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and was passed through a 4B-CL Sepharose column (5 by 95 cm) equilibrated in 0.2 M NaCl. The void volume fractions were stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Polysera |
Antibody Type Class | Mainly IgG, particularly IgG1 and IgG3 |
Assay System | Double immunodiffusion, capillary precipitation, ELISA |
Cross Reactivity | N/A |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | Antibodies elicited by the conjugates had in vitroopsonic activities proposed to be a correlate of protective immunity |
Curator ID | AA + AS |
Date of Curation | 04-01-2010 |
References | PMC258520 |
PolysacDB ID | 1016 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 21D2 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody cross-reacted with Serotype A, D and GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1017 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 14A12 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1018 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 11E2 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1019 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 7B13 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1020 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 12G5 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 06-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1021 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 20C5 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 06-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1022 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 20B5 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 06-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1023 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 4H3 |
Antibody Type Class | IgG3 |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 07-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1024 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed Function | The capsular polysaccharide is an important virulence factor |
Antigenic Nature | Cryptococci cells |
Carrier Name | N/A |
Conjugate Method | N/A |
Antibodies | Mab 15C6 |
Antibody Type Class | IgA |
Assay System | Immunofluorescence |
Cross Reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed Epitope | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 07-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1070 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Neisseria meningitidis Serogroup B (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide, also known as K-antigen consists of repeating units of following residues : -8)α-Neup5Ac(2- [a homopolymer of α(2-->8) sialic acid residues] |
BCSDB Structure | 139710 |
Proposed Function | N/A |
Antigenic Nature | Live group B type 15 meningococci cells |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Mab 2-2-B |
Antibody Type Class | IgM |
Assay System | ELISA and Radioimmunoassay |
Cross Reactivity | This antibody cross-reacted with E. coli strain K1 Capsular polysaccharide |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab provided protection against the E. coli K-1 strain |
Curator ID | AA + AS |
Date of Curation | 21-01-2010 |
References | PMC261141 |
PolysacDB ID | 1109 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Actinobacillus pleuropneumoniae serotype 1 FMV87-682 (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | N/A |
Antigenic Nature | Formalinized whole cell antigen (WCA) |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Mab F11-7F |
Antibody Type Class | IgM |
Assay System | ELISA, immunoblotting |
Cross Reactivity | This Mab did not recognize other bacterial species, such as A. lignieresii, A. suis, A. rossii, Haemophilus spp., H. parasuis, P. multocida, P. suis, B. bronchiseptica, and E. coli |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab was proposed to stabilize the capsule.This MAb could be useful for serotyping analysis in actinobacillus strains |
Curator ID | AA + AS |
Date of Curation | 01-02-2010 |
References | 9249182 |
PolysacDB ID | 1112 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Actinobacillus pleuropneumoniae serotype 1 shope 4074 (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | N/A |
Antigenic Nature | Formalinized whole cell antigen (WCA) |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Mab 1.5C5F4 |
Antibody Type Class | IgM |
Assay System | ELISA, immunoblotting |
Cross Reactivity | This antibody specifically reacted with Serotype1 only |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | This MAb could be useful for serotyping analysis in actinobacillus strains |
Curator ID | AA + AS |
Date of Curation | 02-02-2010 |
References | 9249182 |
PolysacDB ID | 1124 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Actinobacillus pleuropneumoniae serotype 1 (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | N/A |
Antigenic Nature | Whole cells |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Polysera |
Antibody Type Class | N/A |
Assay System | ELISA |
Cross Reactivity | This antibody was specific to serotype 1 only |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | N/A |
Curator ID | AA + AS |
Date of Curation | 07-02-2010 |
References | PMC206369 |
PolysacDB ID | 1137 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Actinobacillus pleuropneumoniae serotype 1 (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | N/A |
Antigenic Nature | Whole cells |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | LMab-1 |
Antibody Type Class | IgM |
Assay System | ELISA inhibition tests |
Cross Reactivity | LMAb-1 reacted to only a serotype 1, strain 4074 |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab can be useful for serotyping studies |
Curator ID | AA + AS |
Date of Curation | 13-02-2010 |
References | 1382625 |
PolysacDB ID | 1142 |
Carbohydrate Name | Capsular Polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Bacteroides fragilis NCTC 9343 (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | Capsular polysaccharide of B. fragilis may represent a virulence factor |
Antigenic Nature | Whole cells of B. fragilis NCTC 9343 |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Mab BF4 |
Antibody Type Class | IgM |
Assay System | ELISA, Enzyme Immunoassay and immunoblotting |
Cross Reactivity | MAb Bf4 did not cross react with the sixteen Bacteroides species and strains tested |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | N/A |
Curator ID | AA + AS |
Date of Curation | 14-02-2010 |
References | 3309142 |
PolysacDB ID | 1157 |
Carbohydrate Name | Capsular Polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Bacteroides fragilis strain 638R (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | Capsular polysaccharide of B. fragilis may represent a virulence factor |
Antigenic Nature | Whole cells of B. fragilis strain 638R |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Polysera |
Antibody Type Class | N/A |
Assay System | Immunodiffusion |
Cross Reactivity | N/A |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antisera helped in the discovery of 3 different types of surface polysaccharides on the capsule |
Curator ID | AA + AS |
Date of Curation | 21-02-2010 |
References | PMC98163 |
PolysacDB ID | 1463 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Enterococcus faecalis (NCBI Taxonomy) (Drugpedia) |
Basic Structure | Glycerol teichoic acid-like molecules with a carbohydrate backbone structure of 6-α-D-glucose- 1-->2 glycerol-3-PO4 with substitution on carbon 2 of the glucose with an α-2-1-D-glucose residue |
BCSDB Structure | 2446 |
Proposed Function | These polysaccharides are major virulence factors |
Antigenic Nature | Nil |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Healthy human sera |
Antibody Type Class | IgG and IgM |
Assay System | ELISA |
Cross Reactivity | The antisera bound to all 4 serotypes of E. fecalis CPS-A to CPS-D |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | These antibodies promote neutrophil mediated killing |
Curator ID | AA + AS |
Date of Curation | 24-07-2010 |
References | PMC1182185 |
PolysacDB ID | 1464 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Enterococcus faecalis 12030 (NCBI Taxonomy) (Drugpedia) |
Basic Structure | Glycerol teichoic acid-like molecules with a carbohydrate backbone structure of 6-α-D-glucose- 1-->2 glycerol-3-PO4 with substitution on carbon 2 of the glucose with an α-2-1-D-glucose residue |
BCSDB Structure | 2446 |
Proposed Function | These polysaccharides are major virulence factors |
Antigenic Nature | Gentamicin-killed Enterococcus faecalis strains |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Polysera |
Antibody Type Class | N/A |
Assay System | Opsonophagocytic assay, immunoelectron microscopy |
Cross Reactivity | This antisera reacted with the homologous strain (12030) and mediated opsonic killing of 33% of all strains tested. In addition, this serum killed two (28%) of seven vancomycin-resistant Enterococcus faecium strains |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antisera was opsonophagcytic |
Curator ID | AA + AS |
Date of Curation | 24-07-2010 |
References | 10024563 |
PolysacDB ID | 1465 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Enterococcus faecalis 12030 (NCBI Taxonomy) (Drugpedia) |
Basic Structure | Glycerol teichoic acid-like molecules with a carbohydrate backbone structure of 6-α-D-glucose- 1-->2 glycerol-3-PO4 with substitution on carbon 2 of the glucose with an α-2-1-D-glucose residue |
BCSDB Structure | 2446 |
Proposed Function | These polysaccharides are major virulence factors |
Antigenic Nature | Capsular polysaccharide |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Polysera |
Antibody Type Class | IgM |
Assay System | ELISA and opsonophagocytic assay |
Cross Reactivity | The antisera cross-reacted with Enterococcus faecalis OG1RF and against two serologically related, vancomycin-resistant Enterococcus faecium clinical isolates |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | These antibodies may be useful for prophylaxis and treatment of enterococcal infections |
Curator ID | AA + AS |
Date of Curation | 25-07-2010 |
References | 15184433 |
PolysacDB ID | 1494 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans Serotype A [strain 24064] (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The major component of C. neoformans capsular polysaccharide is glucurunoxylomannan [GXM] consisting of an unbranched mannose backbone substituted with xylose, glucuronic acid and O-acetyl residues |
BCSDB Structure | N/A |
Proposed Function | C. neoformans has a large polysaccharide capsule that is a determinant of virulence. The capsular polysaccharide causes immunologic paralysis and inhibits phagocytosis by macrophages. Soluble C. neoformans capsular polysaccharide enhances human immunodeficiency virus [HIV] infection in cultured cells, suggesting a new pathogenic role in AIDS |
Antigenic Nature | Whole cells |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Polysera |
Antibody Type Class | IgG [predominantly IgG1] |
Assay System | ELISA |
Cross Reactivity | This antibody cross-reacted with Serotype D strains |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | N/A |
Curator ID | AA + AS |
Date of Curation | 03-08-2010 |
References | 1583327 |
PolysacDB ID | 1495 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans Serotype A [strain 24064] (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The major component of C. neoformans capsular polysaccharide is glucurunoxylomannan [GXM] consisting of an unbranched mannose backbone substituted with xylose, glucuronic acid and O-acetyl residues |
BCSDB Structure | N/A |
Proposed Function | C. neoformans has a large polysaccharide capsule that is a determinant of virulence. The capsular polysaccharide causes immunologic paralysis and inhibits phagocytosis by macrophages. Soluble C. neoformans capsular polysaccharide enhances human immunodeficiency virus [HIV] infection in cultured cells, suggesting a new pathogenic role in AIDS |
Antigenic Nature | Whole cells |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Polysera |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody cross-reacted with Serotype D strains |
Proposed Epitope | N/A |
IEDB Epitope | N/A |
Proposed Utility | N/A |
Curator ID | AA + AS |
Date of Curation | 03-08-2010 |
References | 1583327 |
PolysacDB ID | 1497 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Cryptococcus neoformans Serotype A [strain 24064] (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The major component of C. neoformans capsular polysaccharide is glucurunoxylomannan [GXM] consisting of an unbranched mannose backbone substituted with xylose, glucuronic acid and O-acetyl residues |
BCSDB Structure | N/A |
Proposed Function | The major component of C. neoformans capsular polysaccharide is glucurunoxylomannan [GXM] consisting of an unbranched mannose backbone substituted with xylose, glucuronic acid and O-acetyl residues |
Antigenic Nature | Whole cells |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Mab 5E9 |
Antibody Type Class | IgM |
Assay System | ELISA |
Cross Reactivity | This antibody reacted with 2 serotype A strains 24064 and 371 |
Proposed Epitope | Mab 5E9 bound to de-O-acetylated GXM of strain 371 but not of strain 24064. This shows the probable epitope to be variable among strains and to be acetylation independent |
IEDB Epitope | N/A |
Proposed Utility | N/A |
Curator ID | AA + AS |
Date of Curation | 04-08-2010 |
References | 1583327 |
Bioinformatics Centre, Institute of Microbial Technology, Sec - 39A, Chandigarh, India - 160036 |